Stocks in the News: Palm, Somaxon, Boeing

The following is a round-up of the most active gainers and losers from Thursday's trading session:

Somaxon Pharmaceuticals (SOMX) was the biggest gainer among U.S. stocks, finishing up a whopping 137%, or $5.32 per share, on news that it received FDA approval for an insomnia drug.

Delta Petroleum (DPTR) surged 30%, or 41 cents per share, after its planned sale of a stake in a large natural gas field in Colorado.

Nike (NKE) rose 5.4%, or $3.81 per share, after a positive earnings report late Wednesday.

Google (GOOG) grew slightly, ending the day up 84 cents per share; Intel (INTC) fell slightly, or 4 cents per share; and Sony (SNE) rose 1.5%, or 56 cents per share. Several reports said the trio will work together to create Internet-enabled televisions and set top boxes.

Viacom (VIA) rose a half percent, or 19 cents per share, after unsealed documents offered details of a fight between the company and Google's YouTube.

Barnes and Noble (BKS) increased 2.5%, or 57 cents per share, after a chief executive shake up.

FedEx (FDX) shares set a 52-week high at $92.67 per share, growing 3%, or $2.87 per share, on better-than-expected earnings.

Palm (PALM), which ended the day up 5% , or 28 cents per share, got an unexpected boost in anticipation of a third-quarter earnings announcement late Thursday.

Boeing (BA) hit a 52-week high, increasing 2.2 %, or $1.49 per share, and leading advancers on the Dow.
Read Full Story

Markets

DJIA 21,674.51 -76.22 -0.35%
NASDAQ 6,216.53 -5.39 -0.09%
S&P 500 2,425.55 -4.46 -0.18%
NIKKEI 225 19,470.41 -232.22 -1.18%
HANG SENG 27,047.57 -296.65 -1.08%
DAX 12,165.19 -38.27 -0.31%
USD (per EUR) 1.18 0.00 0.40%
USD (per CHF) 0.96 0.00 0.29%
JPY (per USD) 109.20 -0.12 -0.11%
GBP (per USD) 1.29 0.00 0.08%

Can't get enough business news?

Sign up for Finance Report by AOL and get everything from retailer news to the latest IPOs delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.